Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2. 2007

Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology, Seoul, Korea.

Schisandra fruits (Schisandraceae) are often used in traditional medicine and can be taken concomitantly with conventional medicine. In this study, the effects of dibenzocyclooctadiene lignans from Schizandra chinensis on P-gp-mediated efflux were examined to investigate a possible interaction with P-gp substrates. The cellular accumulation of rhodamine-123 in Caco-2 cells was measured with 12 Schisandra lignans. Most compounds resulted in slight or moderate increases of rhodamin-123 cellular uptake, indicating their P-gp inhibitory activity. Among them, deoxyschizandrin exhibited the most potent effect on the accumulation of rhodamine-123. Subsequently, bidirectional transports of digoxin and rhodamine-123 in Caco-2 cells were determined with deoxyschizandrin, the most active compound for the rhodamine-123 assay. In the bidirectional transport study, apical-to-basal (A-to-B) transports of digoxin and rhodamine-123 were increased, whereas basal-to-apical (B-to-A) transports were decreased by deoxyschizandrin in concentration- and time-dependent manners. At 50 microM of deoxyschizandrin, the transport ratios (B-A/A-B) for digoxin and rhodamine-123 were 2.2 and 2.1 compared with the control ratios of 15.2 and 12.2, respectively. These results demonstrated that deoxyschizandrin effectively inhibited the P-gp-mediated efflux in Caco-2 cells, suggesting they could potentially increase the absorption of drugs that can act as a P-gp substrate.

UI MeSH Term Description Entries
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D017705 Lignans A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Lignan,Neolignan,Neolignans
D018938 Caco-2 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation. Caco 2 Cells,Caco-2 Cell,Cell, Caco-2,Cells, Caco-2
D020112 Rhodamine 123 A fluorescent probe with low toxicity which is a potent substrate for ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 and the bacterial multidrug efflux transporter. It is used to assess mitochondrial bioenergetics in living cells and to measure the efflux activity of ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 in both normal and malignant cells. (Leukemia 1997;11(7):1124-30)
D020168 ATP Binding Cassette Transporter, Subfamily B, Member 1 A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE). ATP-Dependent Translocase ABCB1,MDR1 Protein,MDR1B Protein,Multidrug Resistance Protein 1,P-Glycoprotein,P-Glycoprotein 1,ABCB1 Protein,ATP Binding Cassette Transporter, Sub-Family B, Member 1,ATP-Binding Cassette, Sub-Family B, Member 1,CD243 Antigen,PGY-1 Protein,1, P-Glycoprotein,ABCB1, ATP-Dependent Translocase,ATP Dependent Translocase ABCB1,Antigen, CD243,P Glycoprotein,P Glycoprotein 1,PGY 1 Protein,Protein, MDR1B,Translocase ABCB1, ATP-Dependent
D032141 Schisandra A plant genus of the family Schisandraceae which contain schisandrins (Russian) which are also called gomisins (Japanese) or wuweizins (Chinese). Compounds produced by this genus are very similar in composition and use to that of the related KADSURA plant. Gomisi,Schizandra,Wu wei zi,Wuweizi,Bay Starvine,Schisandra chinensis,Schisandra glabra,Bay Starvines,Starvine, Bay,Starvines, Bay
D034242 Cyclooctanes A group of compounds with an 8-carbon ring. They may be saturated or unsaturated. Benzocyclooctanes,Benzocyclooctenes,Cyclooctenes,Cyclooctodienes,Dibenzocyclooctanes

Related Publications

Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
December 2004, Bioscience, biotechnology, and biochemistry,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
December 2016, Fundamental & clinical pharmacology,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
January 2004, Journal of drug targeting,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
May 1993, Pharmaceutical research,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
January 2018, Journal of agricultural and food chemistry,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
February 2001, The Journal of pharmacology and experimental therapeutics,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
December 2012, Journal of ethnopharmacology,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
June 1998, Journal of pharmaceutical sciences,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
July 2001, The Journal of pharmacology and experimental therapeutics,
Hye Hyun Yoo, and Mijin Lee, and Min Woo Lee, and Sun Young Lim, and Jongheon Shin, and Dong-Hyun Kim
February 2018, ACS omega,
Copied contents to your clipboard!